|
|
|
|
|
Sponsored by: |
Pfizer |
Information provided by: | Pfizer |
ClinicalTrials.gov Identifier: | NCT00705601 |
To begin to refine development of the RSQ (Restorative Sleep Questionnaire) measure in subjects with NRS (Nonrestorative Sleep) by generating item content pertaining to morning refreshment and uncovering problems in instrument administration in subjects with nonrestorative sleep
Condition | Intervention | Phase |
Nonrestorative Sleep |
Procedure: PSG |
Phase II |
Study Type: | Interventional |
Study Design: | Screening, Non-Randomized, Open Label, Single Group Assignment |
Official Title: | Refinement Of Patient Reported Outcomes Instruments In Subjects With Insomnia Characterized By Nonrestorative Sleep |
Estimated Enrollment: | 65 |
Study Start Date: | July 2008 |
Estimated Study Completion Date: | June 2009 |
Estimated Primary Completion Date: | June 2009 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
1 |
Procedure: PSG
PSG (polysomnography) for adaptation night, day 2 evening, and day 3 evening--used to identify suitable Nonrestorative Sleep candidates to participate in focus groups.
|
Ages Eligible for Study: | 18 Years to 64 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Pfizer CT.gov Call Center | 1-800-718-1021 |
United States, California | |||||
Pfizer Investigational Site | Not yet recruiting | ||||
Pasadena, California, United States, 91106 | |||||
Pfizer Investigational Site | Recruiting | ||||
San Diego, California, United States, 92121 | |||||
Pfizer Investigational Site | Recruiting | ||||
Fountain Valley, California, United States, 92708 | |||||
United States, Florida | |||||
Pfizer Investigational Site | Not yet recruiting | ||||
Pembroke Pines, Florida, United States, 33026 | |||||
United States, Kentucky | |||||
Pfizer Investigational Site | Not yet recruiting | ||||
Crestview Hills, Kentucky, United States, 41017 | |||||
Pfizer Investigational Site | Not yet recruiting | ||||
Louisville, Kentucky, United States, 40217 | |||||
United States, Ohio | |||||
Pfizer Investigational Site | Not yet recruiting | ||||
Columbus, Ohio, United States, 43213 |
Pfizer |
Study Director: | Pfizer CT.gov Call Center | Pfizer |
To obtain contact information for a study center near you, click here. 
  |
Responsible Party: | Pfizer, Inc. ( Director, Clinical Trial Disclosure Group ) |
Study ID Numbers: | A9001380 |
First Received: | June 24, 2008 |
Last Updated: | September 15, 2008 |
ClinicalTrials.gov Identifier: | NCT00705601 |
Health Authority: | United States: Food and Drug Administration |
|